Dexcom Inc (DXCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 696,200 | 628,800 | 698,200 | 650,200 | 595,100 |
| Cost of Goods | 246,700 | 230,700 | 225,600 | 203,300 | 178,000 |
| Gross Profit | 449,500 | 398,100 | 472,600 | 446,900 | 417,100 |
| Operating Expenses | 373,200 | 357,500 | 472,600 | 328,900 | 316,100 |
| Operating Income | 77,000 | 41,300 | 600 | 118,300 | 101,000 |
| Interest Expense | 4,700 | 4,600 | 0 | 4,600 | 4,800 |
| Other Income | 3,000 | -600 | 5,800 | -1,700 | 900 |
| Pre-tax Income | 75,300 | 36,100 | 6,400 | 112,000 | 97,100 |
| Income Tax | 24,400 | -61,200 | 11,700 | 24,700 | 18,700 |
| Net Income Continuous | 50,900 | 97,300 | -5,300 | 87,300 | 78,400 |
| Net Income | $50,900 | $97,300 | $-5,300 | $87,300 | $78,400 |
| EPS Basic Total Ops | 0.13 | 0.25 | -0.02 | 0.23 | 0.20 |
| EPS Basic Continuous Ops | 0.13 | 0.25 | -0.01 | 0.23 | 0.20 |
| EPS Diluted Total Ops | 0.12 | 0.23 | -0.01 | 0.21 | 0.19 |
| EPS Diluted Continuous Ops | 0.12 | 0.23 | -0.02 | 0.20 | 0.18 |
| EBITDA(a) | $120,600 | $78,100 | $32,700 | $143,800 | $124,500 |